Actively Recruiting

Phase 2
Age: 18Years - 70Years
All Genders
NCT07349472

Pentoxifylline in Patients With Ulcerative Colitis

Led by Ihab Elsayed Hassan · Updated on 2026-04-15

60

Participants Needed

1

Research Sites

56 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Ulcerative colitis (UC) is a persistent, idiopathic form of inflammatory bowel disease (IBD) marked by uninterrupted inflammation of the colon's mucosal lining, usually starting at the rectum and progressing proximally in a continuous manner. It manifests clinically with recurrent episodes of abdominal pain, bloody diarrhea, urgency, tenesmus, and weight loss. The precise cause of UC is still unknown; however, it is thought to arise from a multifactorial interaction involving genetic susceptibility, immune system dysregulation, disturbances in gut microbiota composition, and various environmental factors.

CONDITIONS

Official Title

Pentoxifylline in Patients With Ulcerative Colitis

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 218 years
  • Both male and female participants are eligible
  • Negative pregnancy test and use of effective contraception for women of childbearing potential
  • Diagnosed with mild or moderate ulcerative colitis
Not Eligible

You will not qualify if you...

  • Currently breastfeeding
  • Significant abnormalities in liver or kidney function
  • Diagnosis of diabetes mellitus
  • History of colorectal cancer
  • Severe ulcerative colitis
  • Use of rectal or systemic steroids
  • Use of immunosuppressive or biological therapies
  • Addiction to alcohol or drugs
  • Known allergy to pentoxifylline or mesalamine

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Fayoum University

Al Fayyum, Egypt, 54687

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here